LONG MINI FUTURE WARRANT - NOVO-NORDISK B | Real-time Euronext Paris 11:00:03 18/11/2022 pm IST | ||
| 91.65 EUR | +0.49% |
|
| 1 month | +1.70% | ||
| 3 months | +9.07% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
Static data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | Goldman Sachs |
| A5IPH | |
| ISIN | NL0011989132 |
| Date issued | 13/10/2016 |
| Strike | 61.1 kr |
| Maturity | Unlimited |
| Parity | 0.5 : 1 |
| Emission price | 13.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 99.37 € |
|---|---|
| Lowest since issue | 7.76 € |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3
DKK
Average target price
917.2
DKK
Spread / Average Target
-1.09%
- Stock Market
- Certificates
- A5IPH Certificat
